1306763-57-4 Usage
Description
(S)-1-amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride is a chiral compound derived from indene, featuring both an amino and a carbonitrile group. As a hydrochloride salt, it possesses potential biological activity and serves as a versatile building block in the synthesis of various organic molecules, particularly in pharmaceutical and chemical research.
Uses
Used in Pharmaceutical Research:
(S)-1-amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride is utilized as a chiral building block for the development of new pharmaceutical agents, leveraging its unique structural features to create novel drug candidates with potential therapeutic applications.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (S)-1-amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride is employed as a key intermediate in the synthesis of biologically active molecules, contributing to the discovery of new drugs with improved efficacy and selectivity.
Used in Chemical Research:
(S)-1-amino-2,3-dihydro-1H-indene-4-carbonitrile hydrochloride serves as a valuable compound in chemical research, enabling the exploration of its reactivity and potential applications in organic synthesis, including the creation of new chemical entities with diverse properties and functions.
Check Digit Verification of cas no
The CAS Registry Mumber 1306763-57-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,6,7,6 and 3 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1306763-57:
(9*1)+(8*3)+(7*0)+(6*6)+(5*7)+(4*6)+(3*3)+(2*5)+(1*7)=154
154 % 10 = 4
So 1306763-57-4 is a valid CAS Registry Number.
1306763-57-4Relevant articles and documents
IMPROVED PROCESS FOR PREPARING OZANIMOD
-
Page/Page column 17, (2020/07/04)
The presented invention relates to a process for preparation of compound of formula (1) or a salt thereof (i.e.) ozanimod : (1). The invention also relates to intermediates used in the process.
COMPOUNDS AND METHODS FOR TREATING LUPUS
-
Page/Page column 56, (2018/04/17)
Methods for treatment of systemic lupus erythematosus (SLE" or "Lupus") by administration of a modulator of sphingosine-1-phosphate receptor subtype 1 (S1P1), as well as compositions and methods related to the same, wherein such S1P1 modulators have the f
